Literature DB >> 31964753

Cell Cycle-Dependent Switch of TopBP1 Functions by Cdk2 and Akt.

Kang Liu1, Joshua D Graves1,2, Yu-Ju Lee1,3, Fang-Tsyr Lin1, Weei-Chin Lin4,2,3,5.   

Abstract

Cdk2-dependent TopBP1-treslin interaction is critical for DNA replication initiation. However, it remains unclear how this association is terminated after replication initiation is finished. Here, we demonstrate that phosphorylation of TopBP1 by Akt coincides with cyclin A activation during S and G2 phases and switches the TopBP1-interacting partner from treslin to E2F1, which results in the termination of replication initiation. Premature activation of Akt in G1 phase causes an early switch and inhibits DNA replication. TopBP1 is often overexpressed in cancer and can bypass control by Cdk2 to interact with treslin, leading to enhanced DNA replication. Consistent with this notion, reducing the levels of TopBP1 in cancer cells restores sensitivity to a Cdk2 inhibitor. Together, our study links Cdk2 and Akt pathways to the control of DNA replication through the regulation of TopBP1-treslin interaction. These data also suggest an important role for TopBP1 in driving abnormal DNA replication in cancer.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Akt; Cdk2; TopBP1; cyclin A; treslin

Year:  2020        PMID: 31964753      PMCID: PMC7108819          DOI: 10.1128/MCB.00599-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  Treslin collaborates with TopBP1 in triggering the initiation of DNA replication.

Authors:  Akiko Kumagai; Anna Shevchenko; Andrej Shevchenko; William G Dunphy
Journal:  Cell       Date:  2010-01-28       Impact factor: 41.582

2.  Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts.

Authors:  Emily E Arias; Johannes C Walter
Journal:  Genes Dev       Date:  2004-12-14       Impact factor: 11.361

3.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Authors:  Michael Hummel; Stefan Bentink; Hilmar Berger; Wolfram Klapper; Swen Wessendorf; Thomas F E Barth; Heinz-Wolfram Bernd; Sergio B Cogliatti; Judith Dierlamm; Alfred C Feller; Martin-Leo Hansmann; Eugenia Haralambieva; Lana Harder; Dirk Hasenclever; Michael Kühn; Dido Lenze; Peter Lichter; Jose Ignacio Martin-Subero; Peter Möller; Hans-Konrad Müller-Hermelink; German Ott; Reza M Parwaresch; Christiane Pott; Andreas Rosenwald; Maciej Rosolowski; Carsten Schwaenen; Benjamin Stürzenhofecker; Monika Szczepanowski; Heiko Trautmann; Hans-Heinrich Wacker; Rainer Spang; Markus Loeffler; Lorenz Trümper; Harald Stein; Reiner Siebert
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.

Authors:  Kang Liu; Naresh Bellam; Hui-Yi Lin; Bing Wang; Cecil R Stockard; William E Grizzle; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

5.  Regulation of E2F1 by BRCT domain-containing protein TopBP1.

Authors:  Kang Liu; Fang-Tsyr Lin; J Michael Ruppert; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials.

Authors:  Wolfram Klapper; Monika Szczepanowski; Birgit Burkhardt; Hilmar Berger; Maciej Rosolowski; Stefan Bentink; Carsten Schwaenen; Swen Wessendorf; Rainer Spang; Peter Möller; Martin Leo Hansmann; Heinz-Wolfram Bernd; German Ott; Michael Hummel; Harald Stein; Markus Loeffler; Lorenz Trümper; Martin Zimmermann; Alfred Reiter; Reiner Siebert
Journal:  Blood       Date:  2008-05-28       Impact factor: 22.113

Review 7.  Preventing re-replication of chromosomal DNA.

Authors:  J Julian Blow; Anindya Dutta
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

8.  Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.

Authors:  Pinki Chowdhury; Gregory E Lin; Kang Liu; Yongcheng Song; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Nat Commun       Date:  2014-11-17       Impact factor: 14.919

Review 9.  TopBP1: A BRCT-scaffold protein functioning in multiple cellular pathways.

Authors:  Christopher P Wardlaw; Antony M Carr; Antony W Oliver
Journal:  DNA Repair (Amst)       Date:  2014-07-30

10.  Targeted biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers.

Authors:  Erica B Schleifman; Rupal Desai; Jill M Spoerke; Yuanyuan Xiao; Cheryl Wong; Ilma Abbas; Carol O'Brien; Rajesh Patel; Teiko Sumiyoshi; Ling Fu; Rachel N Tam; Hartmut Koeppen; Timothy R Wilson; Rajiv Raja; Garret M Hampton; Mark R Lackner
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more
  4 in total

1.  Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.

Authors:  Yan Zhao; Xinping Huang; Dan Zhu; Min Wei; Jiechen Luo; Shuyu Yu; Yonglu Tian; Xiaofeng Zheng
Journal:  Cell Death Differ       Date:  2022-06-29       Impact factor: 15.828

2.  The Role of DNA Topoisomerase Binding Protein 1 (TopBP1) in Genome Stability in Arabidopsis.

Authors:  Pablo Parra-Nunez; Claire Cooper; Eugenio Sanchez-Moran
Journal:  Plants (Basel)       Date:  2021-11-24

3.  Identification and Validation of Autophagy-Related Genes as Potential Biomarkers and Therapeutic Targets in Atrial Fibrillation.

Authors:  Jiao Zhou; Yunlong Dong; Xiang Cai; Hongbo Yang; Tao Guo
Journal:  Int J Gen Med       Date:  2021-11-06

4.  Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic.

Authors:  Yuewen Zhang; Lei Wu; Zhao Wang; Jinpeng Wang; Shrabasti Roychoudhury; Bartlomiej Tomasik; Gang Wu; Geng Wang; Xinrui Rao; Rui Zhou
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.